Blue rubber bleb nevus syndrome with disseminated intravascular coagulation and thrombocytopenia: successful treatment with high-dose intravenous gammaglobulin.
A 63-year-old woman was diagnosed as having blue rubber bleb nevus syndrome (BRBNS) with disseminated intravascular coagulation (DIC). Hematological data showed typical DIC: PT 13.2 sec, activated PTT 55.3 sec, fibrinogen 20 mg/100 ml, FDP-E 928 ng/ml, D-dimer 3,477 ng/ml, platelet count 25 x 10(3)/microliters. Although hypofibrinogenemia was successfully controlled by the continuous infusion of heparin, 10,000 units/day, thrombocytopenia has continued. Based on shortened platelet life span, high level of platelet associated IgG, and increased number of megakaryocyte in the bone marrow, the thrombocytopenia was thought to be due to antiplatelet antibody. Her platelet count returned to normal after intravenous infusion of high-dose gamma globulin (IVIg, Sandoz) at the dose of 400 mg/kg for 2-5 days, while corticosteroid, Gabexate mesilate, synthetic thrombin inhibitor MD-805, urinastatin and warfarin had no effect. Thus, DIC or thrombocytopenia may become a serious complication in some patients with BRBNS and IVIg may be useful for correcting thrombocytopenia in the patient.
Aihara
M
M
First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki.
Konuma
Y
Y
Okawa
K
K
Komai
R
R
Kudo
I
I
Morioka
R
R
Kariya
K
K
Takami
H
H
Sawada
Y
Y
Munakata
A
A
D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy*; D005260:Female; D005264:Femoral Fractures / Q000150:complications; D006391:Hemangioma / Q000150:complications / Q000151:congenital; D006801:Humans; D007116:Immunization, Passive; D007275:Injections, Intravenous; D008875:Middle Aged; D009506:Nevus / Q000150:complications* / Q000151:congenital; D012878:Skin Neoplasms / Q000150:complications* / Q000151:congenital; D013577:Syndrome; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy*